Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study
Authors:
- James D. MillerJMJames D. Miller
- Judith KnittleJKJudith Knittle
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 54 (3) , 419-427
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomataFertility and Sterility, 1989
- A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosisFertility and Sterility, 1988
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- Luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.The Journal of Clinical Endocrinology & Metabolism, 1982
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectivenessAmerican Journal of Obstetrics and Gynecology, 1981
- SOME ATHEROGENIC CONCOMITANTS OF MENOPAUSE: THE FRAMINGHAM STUDYAmerican Journal of Epidemiology, 1976